Additionally, antithrombotic therapy with aspirin or P2Y12 inhibitors, beta‐blockers, ACE inhibitors, or ARBs is recommended for specific clinical profiles, such as those with a history of myocardial infarction (MI), heart failure or hypertension. This evidence concerns the gene ACE and myocardial infarction.